Latest News Archive

Please select Category, Year, and then Month to display items

SASL Star: Lerato Sheila Thamahane

22 September 2021 | Story Michelle Nöthling | Photo Supplied

Lerato Thamahane may be able to speak and understand all nine of South Africa’s official African languages, but it is a tenth language she is devoting her life to: South African Sign Language (SASL).

With nearly ten years’ experience as a SASL interpreter in several settings – ranging from the medical and mental-health fields to that of conferences and Deafblind interpreting – Lerato is living her life’s purpose. “I regard myself as a member of the Deaf community and a servant at the same time.”

Lerato lives by the principle that the more perspectives she gains on the world, the better service as an interpreter she can provide. This is also part of the reason why Lerato decided to take on the role of student again to study BA Language Practice to provide her with an even broader perspective on the field.

But why does Lerato feel so strongly about SASL? It is only through Sign Language, Lerato explains, that one can bridge the divide between the world of the hearing and that of the Deaf. “SASL is the only way for the minority Deaf group to receive and transfer information,” Lerato emphasises. “Deaf people cannot communicate in any other way.” Now, consider for a moment the plight of a Deaf child in South Africa. To receive education in SASL, most Deaf children have to move far away from home at a very young age in order to attend a school for the Deaf. For many years, schools for the Deaf did not include other languages as subjects, which prevented Deaf school-leavers from entering higher education. Although this situation has largely changed, Deaf students are still fighting an uphill battle when entering higher education institutions where prejudice and ignorance still persist. This is where the work of the Centre for Universal Access and Disability Support (CUADS) and the Department of South African Sign Language (SASL) and Deaf Studies makes such a crucial difference.

“I firmly believe,” Lerato says, “that only Sign Language can open opportunities for all groups of the Deaf community – from Deaf children to adults, and from the uneducated to the most educated Deaf people.” It is for this reason, Lerato argues, that our constitution needs to recognise SASL in order to give Deaf people full and equal access to information, to education, and ultimately, to all the opportunities South Africa has to offer.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment

2014-06-27

Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk. Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied

The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept